Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
McKinsey
Accenture
Argus Health
McKesson
Medtronic
Merck
Fuji
Baxter

Generated: December 14, 2018

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR PROTAMINE ZINC INSULIN

« Back to Dashboard

Clinical Trials for Protamine Zinc Insulin

Trial ID Title Status Sponsor Phase Summary
NCT00348231 Jikei Optimal Insulin Therapy in Type 2 Diabetes Unknown status Novo Nordisk A/S N/A The purpose of this study is to compare whether there is the difference in the effect of insulin therapy by the number of times of insulin injection.
NCT00348231 Jikei Optimal Insulin Therapy in Type 2 Diabetes Unknown status Jikei University School of Medicine N/A The purpose of this study is to compare whether there is the difference in the effect of insulin therapy by the number of times of insulin injection.
NCT00474045 Efficacy and Safety of Insulin Detemir Versus Neutral Protamine Hagedorn (NPH) Insulin in Pregnant Women With Type 1 Diabetes Completed Novo Nordisk A/S Phase 3 This trial is conducted in Africa, Europe, North and South America and Oceania. The aim of this trial is to compare the effect and safety on blood glucose control in pregnant women with type 1 diabetes of a modern insulin analogue (insulin detemir) and human insulin (NPH insulin) given as long-acting insulin in combination with a short-acting insulin (insulin aspart).
NCT00487240 Comparison of Two Basal Insulin Therapies for Patients With Type 1 Diabetes Completed Eli Lilly and Company Phase 3 The purpose of this study is to examine the efficacy and safety of insulin lispro protamine suspension (ILPS) as compared to insulin detemir as basal insulin combined with mealtime insulin therapy in patients with type 1 diabetes. A gatekeeper strategy will be employed for sequentially testing the secondary objectives.
NCT00490854 A Study for Patients With Type 2 Diabetes Mellitus Completed Alkermes, Inc. Phase 2/Phase 3 The purpose of the study is to compare the human insulin inhalation powder plus oral anti-hyperglycemic medication with injected insulin (neutral protamine hegedom insulin) plus oral anti-hyperglycemic medication on lowering the blood sugar level.
NCT00490854 A Study for Patients With Type 2 Diabetes Mellitus Completed Eli Lilly and Company Phase 2/Phase 3 The purpose of the study is to compare the human insulin inhalation powder plus oral anti-hyperglycemic medication with injected insulin (neutral protamine hegedom insulin) plus oral anti-hyperglycemic medication on lowering the blood sugar level.
Trial ID Title Status Sponsor Phase Summary

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Clinical Trial Conditions for Protamine Zinc Insulin

Condition Name

Condition Name for Protamine Zinc Insulin
Intervention Trials
Diabetes Mellitus, Type 2 13
Diabetes 8
Type 2 Diabetes Mellitus 7
Type 1 Diabetes Mellitus 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Protamine Zinc Insulin
Intervention Trials
Diabetes Mellitus 33
Diabetes Mellitus, Type 2 24
Diabetes Mellitus, Type 1 8
Hyperglycemia 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Protamine Zinc Insulin

Trials by Country

Trials by Country for Protamine Zinc Insulin
Location Trials
United States 91
South Africa 9
Brazil 8
India 7
United Kingdom 6
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Protamine Zinc Insulin
Location Trials
California 7
New York 5
Texas 5
Georgia 4
Florida 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Protamine Zinc Insulin

Clinical Trial Phase

Clinical Trial Phase for Protamine Zinc Insulin
Clinical Trial Phase Trials
Phase 4 16
Phase 3 15
Phase 2/Phase 3 1
[disabled in preview] 10
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Protamine Zinc Insulin
Clinical Trial Phase Trials
Completed 32
Recruiting 4
Not yet recruiting 2
[disabled in preview] 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Protamine Zinc Insulin

Sponsor Name

Sponsor Name for Protamine Zinc Insulin
Sponsor Trials
Sanofi 8
Eli Lilly and Company 7
Novo Nordisk A/S 7
[disabled in preview] 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Protamine Zinc Insulin
Sponsor Trials
Other 32
Industry 28
U.S. Fed 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
Dow
UBS
Daiichi Sankyo
US Army
Moodys
Merck
Express Scripts
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.